Who we are
Convatec is a global medical products and technologies company focused on solutions for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence care and infusion care.
Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care.
~10,000 employees
~10,000 employees
$2.142 billion revenues in 2023
$2.142 billion revenues in 2023
FTSE100 listing
FTSE100 listing
8 manufacturing sites
8 manufacturing sites
~875M products manufactured
~875M products manufactured
sold in almost 100 countries
sold in almost 100 countries
Our geographic revenue split
53%
53%
33%
33%
14%
14%
Our categories
Advanced Wound Care
Ostomy Care
Continence Care
Infusion Care
Where we operate
Argentina | Costa Rica | Guyana | Peru |
Belize | Curacao | Honduras | Puerto Rico |
Brazil | Dominican Republic | Jamaica | Surinam |
Canada | Ecuador | Mexico | USA |
Chile | El Salvador | Nicaragua | |
Colombia | Guatemala | Panama |
Austria | France | Macedonia | Slovakia |
Belgium | Germany | Malta | Slovenia |
Bosnia & Herzegovina | Greece | Netherlands | Spain |
Bulgaria | Hungary | Norway | Sweden |
Croatia | Iceland | Poland | Switzerland |
Czech Republic | Ireland | Portugal | Turkey |
Denmark | Italy | Romania | Ukraine |
Estonia | Latvia | Serbia | United Kingdom |
Finland | Lithuania |
Australia | Indonesia | Philippines | Thailand |
China | Japan | Singapore | Vietnam |
香港特區 (Hong Kong SAR) | Malaysia | South Korea | |
India | New Zealand | 台灣地區 (Taiwan) |
Bahrain | Israel | Oman | South Africa |
Egypt | Jordan | Pakistan | UAE |
Iran | Kuwait | Qatar | |
Iraq | Lebanon | Saudi Arabia |
More in About us